By Associated Press - Thursday, January 3, 2019

NEW YORK (AP) - Bristol-Myers Squibb to buy Celgene in a cash and stock deal worth $74 billion.

Copyright © 2024 The Washington Times, LLC.

Please read our comment policy before commenting.

Click to Read More and View Comments

Click to Hide